Search

Biofeedback (BF) techniques were developed by psychology in the 1960s having then a long history in which they have proved their usefulness and therapeutic efficacy in a considerable variety of clinical disorders: neurologic, neuromuscular, cardiovascular, gastrointestinal, chronic pain, dermatological, sleep, respiratory, trauma and stress, among many other disorders. Practical applications of the BF include in particular Electroencephalographic Biofeedback (BF-EEG), known as Neurofeedback (NF), whose importance and clinical applications have grown and continue to grow rapidly thanks to the significant development in the fields of neuroscience and computer science on which NF rests. This paper describes and analyzes the technique and process of BF and NF, apart from their methodological foundations but, above all, from a critical point of view, the paper examines their main clinical applications together with the level of utility and therapeutic effectiveness currently achieved. [ABSTRACT FROM AUTHOR]

Background. The complexity in the development of an eating disorder (ED) pose methodological challenges when addressing risk factors of this pathology. Pike et al. (2008) proposed to use a case-control design for this type of research. The eating disorders' risk factor study (ANOBAS) is a case-control study with three control groups aiming to evaluate several variables related to the onset of ED, thus the aim was to illustrate a new methodology proposal and to assess whether the chosen control groups are appropriate to research correlates on ED. Methods. We used a case-control design of 50 female adolescents with ED at onset matched by age and their parents' socioeconomic status with 40 patients with an affective disorder, 40 patients with asthma pathology and 50 without pathology. Diagnoses were completed with K-SADS interview and an evaluation of biological, psychological, environmental and family correlates. Results. Higher similarities were found between the ED group and the affective disorder group across psychological variables, whereas the similarities between the ED group and the asthma group were found at the familial level, as we expected. The biggest differences were found with the non-pathology group. Conclusions. This rigorous research design allows investigating correlates associated specifically to the onset of an ED and the chosen control groups are suitable to investigate it. [ABSTRACT FROM AUTHOR]